Vanda Pharmaceuticals Inc.

VNDA | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.21

+$0.05 (+1.07%)

Sep 22, 2026, 12:51 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-220.47M	-18.9M	2.51M	6.28M	33.15M	23.34M
Depreciation & Amortization	-950K	8.13M	3.01M	2.73M	2.84M	2.86M
Stock-Based Compensation	9.47M	12.43M	14.04M	16.28M	15.37M	13.36M
Other Working Capital	3.42M	4.78M	11.72M	-151K	4.4M	7.2M
Other Non-Cash Items	12.76M	-4.38M	-4.73M	-507K	3.37M	1.71M
Deferred Income Tax	81.44M	-6.48M	-1.29M	1.13M	6.75M	6.19M
Change in Working Capital	8.31M	-6.56M	-747K	6.07M	2.74M	4.32M
Operating Cash Flow	-109.44M	-15.76M	12.8M	31.98M	64.21M	51.78M
Capital Expenditures	-998K	-490K	-383K	-679K	-552K	-1.8M
Cash Acquisitions	n/a	-4.23M	-100.67M	n/a	n/a	n/a
Purchase of Investments	-112.38M	-364.77M	-512.61M	-349.26M	-420.46M	-346.62M
Sales Maturities Of Investments	208.24M	352.06M	601.6M	399.86M	344.32M	306.92M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	94.86M	-17.43M	-12.06M	49.93M	-76.7M	-41.5M
Debt Repayment	-1.99M	-155K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-915K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-2.91M	-155K	n/a	734K	3.55M	5.63M
Net Cash Flow	-17.36M	-33.51M	792K	82.96M	-9.02M	16.02M
Free Cash Flow	-110.44M	-16.25M	12.42M	31.31M	63.66M	49.98M
Adj. Free Cash Flow	-119.91M	-28.68M	-1.62M	15.03M	48.29M	36.62M
Maintenance CapEx	-44.69K	-183.09K	-383K	-679K	n/a	-849.01K
Growth CapEx	-953.32K	-306.91K	n/a	n/a	-552K	-945.99K
Owner Earnings	-109.49M	-15.94M	12.42M	31.31M	64.21M	50.93M